The Tobias group published a paper in the Proceedings of the National Academy of Sciences USA (accessed here) reporting computational modeling of state-dependent structures of the human Hv1 voltage-sensitive proton channel, a membrane protein that is a potential target for therapeutics for treating several diseases, including metastatic breast cancer.